ADSC and SVF: The Unlikely Suspects in Novel ImmunotherapeuticsTuesday, 22 April 2014 at 08:15 Add to Calendar ▼2014-04-21 18:45:002014-04-21 19:45:00Europe/LondonClinical Practicum: Hands-on Demonstration of Adipose-derived Stem Cell Manipulations Ex Vivo at Surgery Center.Clinical Translation of Stem Cells 2014 in Palm Springs, California, USAPalm Springs, California, USASELECTBIOenquiries@selectbiosciences.com Great success has been achieved with dendritic cells (DC) and antigen presentation -based immunotherapeutics for cancer therapy. The rise of this novel cellular therapy has been validated and legitimated with recent FDA approval of Provenge for prostate cancer. Interestingly, Adult Mesenchymal Stem Cells are also capable of antigen presentation in addition to other cells found within SVF. A novel and patent pending method of rapid point-of-care autologous and personalized immunotherapy using the subjects' own SVF and tumor antigen is presented for the first time and exclusively at the Clinical Translation of Stem Cells Summit. Attendees will be offered a first glimpse at a profoundly new field, which patients and the adult stem cell and autologous community will greatly benefit from. Clinical Practicum: Hands-on Demonstration of Adipose-derived Stem Cell Manipulations Ex Vivo at Surgery Center.Monday, 21 April 2014 at 18:45 Add to Calendar ▼2014-04-21 18:45:002014-04-21 19:45:00Europe/LondonClinical Practicum: Hands-on Demonstration of Adipose-derived Stem Cell Manipulations Ex Vivo at Surgery Center.Clinical Translation of Stem Cells 2014 in Palm Springs, California, USAPalm Springs, California, USASELECTBIOenquiries@selectbiosciences.com The Clinical Practicum will be hosted at the following surgery center: |